Literature DB >> 21396358

The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected.

Yaşar Nazligul1, Mehmet Aslan, Mehmet Horoz, Yilmaz Celik, Ahmet Cumhur Dulger, Hakim Celik, Ozcan Erel.   

Abstract

OBJECTIVES: Myeloperoxidase activity has been investigated after eradication of Helicobacter pylori (H. pylori) in infected patients in previous studies but the results are controversial. The aim of this study was to investigate effect on serum myeloperoxidase activity and oxidative status of eradication treatment in H. pylori-infected patients. DESIGN AND METHODS: Gastric biopsy specimens were obtained from 30 H. pylori infected patients. Serum myeloperoxidase activity was measured by enzyme-linked immunoassay. Oxidative status was determined using total antioxidant capacity (TAC) and total oxidant status (TOS) measurement and calculation of oxidative stress index (OSI).
RESULTS: After 2 weeks of the eradication treatment, serum myeloperoxidase activity, TOS and OSI values were significantly lower (all; p<0.001), while TAC was significantly higher (p<0.001).
CONCLUSIONS: Our results indicate that eradication treatment in H. pylori-infected patients may affect both oxidative stress and myeloperoxidase activity which is an important biomarker in pathogenesis of atherosclerosis.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396358     DOI: 10.1016/j.clinbiochem.2011.03.001

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  The evaluation of oxidative stress in the serum and tissue specimens of patients with chronic otitis media.

Authors:  Mehmet Fatih Garça; Mahfuz Turan; Barış Avşar; Ferhat Kalkan; Halit Demir; Ahmet Kozan; Nazım Bozan
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

2.  The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance.

Authors:  Lou Rose Malamug; Rudruidee Karnchanasorn; Raynald Samoa; Ken C Chiu
Journal:  Scientifica (Cairo)       Date:  2014-03-25

Review 3.  Strategies used by helicobacter pylori to establish persistent infection.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

4.  Current Helicobacter pylori infection is significantly associated with subclinical coronary atherosclerosis in healthy subjects: A cross-sectional study.

Authors:  Minyoung Lee; Haeri Baek; Jong Suk Park; Sohee Kim; Chanhee Kyung; Su Jung Baik; Byoung Kwon Lee; Jie-Hyun Kim; Chul Woo Ahn; Kyung Rae Kim; Shinae Kang
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

Review 5.  Relationship Between Helicobacter pylori Infection and Arteriosclerosis.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Jumpei Yamashita; Takahiro Yoshikawa; Akio Namikawa; Rei Isshiki; Hiroko Takahashi; Yuko Shibuya
Journal:  Int J Gen Med       Date:  2021-04-23

6.  Assessment of total (anti)oxidant status in goat kids.

Authors:  Stefano Cecchini; Francesco Fazio
Journal:  Arch Anim Breed       Date:  2021-04-26

7.  Impact of Active Helicobacter pylori Infection-related Metabolic Syndrome on Systemic Arterial Hypertension.

Authors:  Jannis Kountouras; Apostolis Papaefthymiou; Stergios A Polyzos; Evangelos Kazakos; Elisabeth Vardaka; Maria Touloumtzi; Maria Tzitiridou-Chatzopoulou; Christos Liatsos; Ioanna-Konstantina Sgantzou; Jürg Knuchel; Michael Doulberis
Journal:  Arq Bras Cardiol       Date:  2022-09       Impact factor: 2.667

8.  Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome-Mediated Mechanism.

Authors:  Xiujuan Xia; Linfang Zhang; Jingshu Chi; Huan Li; Xiaoming Liu; Tingzi Hu; Rong Li; Yinjie Guo; Xue Zhang; Hui Wang; Jin Cai; Yixi Li; Da Liu; Yuqi Cui; Xilong Zheng; Gregory C Flaker; Duanfang Liao; Hong Hao; Zhenguo Liu; Canxia Xu
Journal:  J Am Heart Assoc       Date:  2020-03-15       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.